Evidence map›Paper›PMID 33881613›Full record

ArticleAmino acids2021

Taurine suppresses liquid-liquid phase separation of lysozyme protein.

Kanae Tsubotani, Sayuri Maeyama, Shigeru Murakami, Stephen W Schaffer, Takashi Ito

Abstract read
PubMed Publisher
In one paragraph

Article in Amino acids, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Metabolites · 2022
    Article
  3. Taurine Stabilizing Effect on Lysozyme.Life (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Kanae TsubotaniDepartment of Biosciences and Biotechnology, Fukui Prefectural University, 4-1-1 Matsuokakenjojima, Eiheiji-cho, Yoshida-gun, Fukui, 910-1195, Japan.
Sayuri MaeyamaDepartment of Biosciences and Biotechnology, Fukui Prefectural University, 4-1-1 Matsuokakenjojima, Eiheiji-cho, Yoshida-gun, Fukui, 910-1195, Japan.
Shigeru MurakamiDepartment of Biosciences and Biotechnology, Fukui Prefectural University, 4-1-1 Matsuokakenjojima, Eiheiji-cho, Yoshida-gun, Fukui, 910-1195, Japan.
Stephen W SchafferCollege of Medicine, University of South Alabama, 5795 Drive North, CSAB 170, Mobile, AL, 36688, USA.
Takashi ItoDepartment of Biosciences and Biotechnology, Fukui Prefectural University, 4-1-1 Matsuokakenjojima, Eiheiji-cho, Yoshida-gun, Fukui, 910-1195, Japan. tito@fpu.ac.jp.ORCID http://orcid.org/0000-0002-1023-587X
Fukui Prefectural University · JPUniversity of South Alabama · US

Funding

Fukui Prefectural University 02R-03-01 (Step-up Research Support Grant)Lotte Foundation (JP) 18-003
6 · The paper itself

Abstract

Taurine is a compatible osmolyte that confers stability to proteins. Recent studies have revealed that liquid-liquid phase separation (LLPS) of proteins underlie the formation of membraneless organelles in cells. In the present study, we evaluated the role of taurine on LLPS of hen egg lysozyme. We demonstrated that taurine decreases the turbidity of the polyethylene glycol-induced crowding solution of lysozyme. We also demonstrated that taurine attenuates LLPS-dependent cloudiness of lysozyme solution with 0.5 or 1 M NaCl at a critical temperature. Moreover, we observed that taurine inhibits LLPS formation of a heteroprotein mix solution of lysozyme and ovalbumin. These data indicate that taurine can modulate the formation of LLPS of proteins.

Indexed as

AnimalsChickensLiquid-Liquid ExtractionMuramidaseTaurinehen egg lysozymeMuramidaseTaurineLiquid–liquid phase separationLysozymeProtein stabilityTaurine

Identifiers

PMID33881613
OpenAlexW3156250354

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.